Mexico

ViiV Healthcare's Positive Action on HIV/AIDS

Set up in 1992, Positive Action is ViiV Healthcare's international HIV/AIDS education, care and community support program. It works with community organizations to build capacity to counter the ignorance and stigma surrounding HIV and AIDS through outreach, education and advocacy. In 2009, ViiV Healthcare provided more than GBP 1 million, funding projects in 46 countries across Africa, Asia, Latin America and Eastern Europe.

Rotavirus Vaccine Program

The Rotavirus Vaccine Program works to accelerate the introduction of new vaccines to treat rotavirus.

Pfizer Global Health Partnerships

Pfizer has a responsibility to direct its resources and expertise to address the world's most enduring health challenges. Cancer is one of these challenges and Pfizer recognizes that only by working together with those who share a vision of a healthier world can we make a significant impact toward eradicating this disease that has outlived too many generations. Pfizer's Global Health Partnerships (GHP) Program is one approach it is taking to tackle the global cancer epidemic.

Pfizer Global Health Fellows

The Pfizer Global Health Fellows program utilizes the professional expertise of Pfizer employees through specialized volunteer assignments with nonprofit organizations to improve health care services for underserved communities around the world. Since 2003, more than 230 employees with a range of technical skills have served in 39 nations for 3-6 month assignments investing nearly 200,000 hours of skills-based service to help increase the capacity of nonprofits organizations providing health care to the underserved (in the reporting period, 54 Global Health Fellows were deployed).

Merck Mectizan Donation Program

Onchocerciasis, or river blindness, is a leading cause of infectious blindness in the developing world. The Merck Mectizan Donation Program (MDP) was launched in 1987, when Merck & Co., Inc. announced that it would donate Mectizan (ivermectin), for the treatment of onchocerciasis to all who needed it for as long as needed.

Merck & Co., Inc. HIV/AIDS Programs - Latin America

With some 720,000 people infected with the HIV virus, Brazil is estimated to have approximately one third of Latin America's HIV-positive population. In response to the epidemic and in support of the Brazilian government's well-recognized commitment to address HIV and AIDS, Merck's Office of Contributions and MSD Brazil provided financial support to HIV programs developed by local nongovernmental organizations, focusing primarily on prevention, education and awareness.

Merck & Co., Inc. HIV/AIDS Programs - Caribbean

Merck has been working in the Caribbean to spur a broader private sector response to HIV and AIDS. Merck recently awarded a grant to the AIDS Responsibility Project, which, in conjunction with the Constella Futures Group, supports the creation of a national business council on HIV and AIDS in Jamaica. The project aims to reduce stigma and discrimination in the workplace and to mobilize companies to formulate specific workplace policies on HIV and AIDS, with the goal of increasing disease awareness and prevention efforts, care, counseling, testing and, if needed, treatment.

Leprosy Elimination

Novartis is providing free treatment for leprosy patients worldwide through its multi-drug therapy.

IMIFAP: HIV/AIDS Education

"I Want to, I Can prevent HIV/AIDS, is the slogan behind the Instituto Mexicano de Investigacion de Familia y Poblacion (IMIFAP) HIV prevention programs, which mobilize citizens to raise neighborhood HIV/AIDS awareness in Mexico. Johnson & Johnson supports an educational program for youth that utilizes the existing national network of middle schools to teach students about HIV prevention before they become sexually active, increasing the likelihood that these adolescents will practice safe sex in the future.

GlaxoSmithKline's PHASE Program

GlaxoSmithKline's Personal Hygiene & Sanitation Education (PHASE) project is helping to reduce diarrhea-related disease by encouraging school children to wash their hands. GSK established PHASE in 1998 and has so far invested over USD 7 million in the program. PHASE is run in partnership with AMREF, Save the Children and Earth Institute at Columbia University, as well as national Ministries of Health and Education in countries where the program is active. The program has had impressive results so far.

Pages